Effects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus
- PMID: 10532516
- DOI: 10.1016/s0002-9149(99)00471-3
Effects of fluvastatin on prothrombotic and fibrinolytic factors in type 2 diabetes mellitus
Abstract
The effects of fluvastatin therapy on parameters of coagulation and fibrinolysis were evaluated in patients with diabetic dyslipidemia in a randomized, placebo-controlled study. Fluvastatin therapy was associated with a small reduction in factor VII coagulant activity, von Willebrand factor, and in plasminogen activator inhibitor 1 and tissue plasminogen activator antigens, but the effects of fluvastatin on hemostatic factors were much less marked than its effects on plasma lipids.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
